PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.

Anne Sophie V M Van den Heerik Nanda HorewegRemi A NoutLudy C H W LutgensElzbieta M van der Steen-BanasikG Henrike WesterveldHetty A van den BergAnnerie SlotFriederike L A KoppeStefan KommossJan Willem M MensMarlies E NoweeStefan BijmoltDavid CibulaTanja C StamIna M Jurgenliemk-SchulzAn SnyersMoritz HamannAleida G ZwanenburgVeronique L M A CoenKatrien VandecasteeleCharles GillhamCyrus ChargariKaren W Verhoeven-AdemaHein PutterWilbert B van den HoutBastiaan G WortmanHans W NijmanTjalling BosseCarien L Creutzberg

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2020)

The trial is registered at clinicaltrials.gov (NCT03469674) and ISRCTN (11659025).

Keyphrases

endometrial cancer
early stage
clinical trial
study protocol
phase iii
randomized controlled trial
phase ii
combination therapy
open label
placebo controlled